LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
US Stock MarketDetailed Quotes
NRIX Nurix Therapeutics
- 19.110
- -0.820-4.11%
Close Dec 27 16:00 ET
- 19.110
- 0.0000.00%
Post 16:20 ET
1.35BMarket Cap-6.59P/E (TTM)
20.220High18.910Low690.50KVolume19.660Open19.930Pre Close13.24MTurnover1.20%Turnover RatioLossP/E (Static)70.84MShares29.56052wk High3.59P/B1.10BFloat Cap7.65052wk Low--Dividend TTM57.74MShs Float52.380Historical High--Div YieldTTM6.57%Amplitude4.220Historical Low19.180Avg Price1Lot Size
About Nurix Therapeutics Company
Nurix Therapeutics, Inc. is a clinical stage biopharmaceutical company. It engages in the business of discovering, developing, and commercializing innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer, inflammatory conditions, and other challenging diseases. The company was founded by John Kuriyan, Michael Rapé, and Arthur Weiss in 2009 and is headquartered in San Francisco, CA.
Company Profile
SymbolNRIX
Company NameNurix Therapeutics
Listing DateJul 24, 2020
Issue Price19.00
Founded2009
CEODr. Arthur T. Sands, M.D.,PhD
MarketNASDAQ
Employees284
Fiscal Year Ends11-30
Address1700 Owens Street,Suite 205
CitySan Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94158
Phone1-415-660-5320
Websitehttp://www.nurixtx.com
Company Executives
- Name
- Position
- Salary
- Dr. Arthur T. Sands, M.D.,PhD
- Director, President and Chief Executive Officer
- 4.36M
- Dr. Christine Ring, J.D.,PhD
- Chief Legal Officer, Chief Compliance Officer and Secretary
- --
- Hans van Houte
- Chief Financial Officer and Principal Accounting Officer
- 1.61M
- Dr. Gwenn Hansen, PhD
- Chief Scientific Officer
- 1.63M
- Dr. David L. Lacey, M.D.
- Chairman of the Board
- 263.29K
- Anil Kapur
- Director
- --
- Paul M. Silva
- Independent Director
- 225.79K
- Judith A. Reinsdorf, J.D.
- Independent Director
- 225.79K
- Edward C. Saltzman
- Independent Director
- 223.29K
- Dr. Lori Anne Kunkel, M.D.
- Independent Director
- 228.29K
- Julia P. Gregory
- Independent Director
- 238.29K